Nonalcoholic fatty liver disease and statins -
Nonalcoholic fatty liver disease and statins Konstantinos Tziomalosa,⁎, Vasilios G. Athyrosb, Paschalis Paschosc, Asterios Karagiannisb a First Propaedeutic. PRACTICE CHANGER. Treat patients with hyperlipidemia and presumed nonalcoholic fatty liver disease with atorvastatin to reduce the risk of cardiovascular events. 1 Non-alcoholic fatty liver disease NAFLD is the most common and emerging liver disease in Western countries 1. Fatty liver includes a wide spectrum of histological alterations ranging from simple steatosis to non-alcoholic steatohepatitis NASH, characterized by inflammation and fibrosis 2.
The efficacy and safety of statins for the treatment of non.
Mar 03, 2011 Do Statins Harm the Liver. that there is damage ongoing to the liver. Statins can be used safely in. will have fatty liver or non. It is possible to develop liver problems with simvastatin. These problems may include jaundice, an increase in liver enzymes. A fatty change in the liver ;
Considerations for Safe Use of Statins Liver Enzyme.
NONALCOHOLIC FATTY LIVER DISEASE. The presence of nonalcoholic fatty liver disease or nonalcoholic steatohepatitis should not deter physicians from using statins in patients with hyperlipidemia. Some studies even suggest that statins may have a beneficial effect on underlying liver disease.12. Liver disease and statins results from studies of statin therapy in patients with elevated liver enzyme levels, nonalcoholic fatty liver disease, hepatitis C, cirrhosis, liver transplants, and hepatocellular carcinoma show benefit without increased risk of adverse effects.